Maier Paul V insider trades
Maier Paul V has filed 17 Form 4s with the SEC that we hold, for Eton Pharmaceuticals, Inc. (ETON) (Director), International Stem Cell CORP (ISCO) (Director), AMAM (Director) and AMAM (Director). Across all of them we count 0 purchases worth $0 and 4 sales worth $3.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($3.0M). The largest single trade was a sale of 36,387 shares of Eton Pharmaceuticals, Inc. worth $2.1M, dated 2026-08-28. Of 4 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-02-28 and the latest 2026-09-17.
Eton Pharmaceuticals, Inc. (ETON)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-28 | S, sale reported on Form 4 | 36,387 | $2.1M | 2026-08-31 |
| 2026-08-28 | S, sale reported on Form 4 | 13,485 | $811.9K | 2026-08-31 |
| 2026-08-28 | S, sale reported on Form 4 | 128 | $7.9K | 2026-08-31 |
International Stem Cell CORP (ISCO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-11 | S, sale reported on Form 4 | 32,802 | $10.5K | 2026-09-15 |
AMAM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
AMAM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1182615) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms